Ireland
--:--IST
Latest
Clinical Trials in Taiwan / NCT07237672
Recruiting Not applicable

AI Based Physiotherapy 3- and 9-Month Follow-Up in Oral Cancer Patients

NCT07237672 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-12-06
Last updated
2025-12-16

Condition(s) studied

Oral Cancer

Investigational drug(s) / intervention(s)

AI-based physiotherapy follow-up assessmentsconventional physiotherapy follow-up assessments

AI-based physiotherapy follow-up assessments: AI-based physiotherapy and 3 and 9 months follow-up assessments

conventional physiotherapy follow-up assessments: conventional physiotherapy and 3 and 9 months follow-up assessments

Study summary

This follow-up clinical study aims to evaluate the sustained effects of two rehabilitation programs (AI-based physiotherapy vs. conventional physiotherapy) for oral cancer patients. Participants who completed the original intervention trial (ClinicalTrials.gov ID: 202411044RINC) will be assessed at 3 and 9 months post-intervention. Outcomes include mandibular mobility, shoulder joint range of motion, functional performance, quality of life, pain, and return-to-work status.

Eligibility

Sex
ALL
Min age
20 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Participants who completed the intervention phase of the previous trial (202411044RINC) * Age 20-65 years * Able to attend follow-up assessments at 3 and 9 months Exclusion Criteria: * Withdrawal from the original trial * Cancer recurrence or new cancer-related treatment interfering with functional assessment * Unable to communicate or comply with follow-up visits

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan Taipei Taiwan Recruiting

More National Taiwan University Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07237672 on ClinicalTrials.gov ↗ ← All trials in Taiwan